Mallinckrodt Plc (NYSE:MNK)

129.61
Delayed Data
As of Mar 27
 +2.83 / +2.23%
Today’s Change
56.12
Today|||52-Week Range
134.26
+30.88%
Year-to-Date

Today’s Trading

Previous close126.78
Today’s open127.63
Day’s range127.50 - 130.32
Volume872,254
Average volume (3 months)1,210,342
Market cap$15.1B
Dividend yield--
Data as of 4:02pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)-582.35%
Earnings growth (this year)+46.95%
Earnings growth (next 5 years)+17.80%
Revenue growth (last year)+15.24%
P/E ratioNM
Price/Sales2.30
Price/Book3.03

Competitors

 Today’s
change
Today’s
% change
HSPHospira Inc+0.03+0.03%
ENDPEndo International P...+2.23+2.54%
INCYIncyte Corp+5.16+5.78%
SLXPSalix Pharmaceutical...-0.03-0.02%
Data as of 4:14pm ET, 03/27/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)$1.54
Annual revenue (last year)$2.5B
Annual profit (last year)-$319.3M
Net profit margin-12.54%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark C. Trudeau
Senior Vice President-
Global Operations
Frank Scholz
Corporate headquarters
Dublin, Dublin

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account